michelle croston...horne r, cooper v, gellaitry g, leake-date h, fisher m. patients'...

32

Upload: others

Post on 14-Oct-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Michelle Croston...Horne R, Cooper V, Gellaitry G, Leake-Date H, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence
Page 2: Michelle Croston...Horne R, Cooper V, Gellaitry G, Leake-Date H, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence

Michelle Croston RN, RHV

Bmed Sci (hons), BA Science (hons), Grad Dip Aesth Medicine. Professional Docturate Student

How  well  do  we  sell  the  adherence  message?      

Page 3: Michelle Croston...Horne R, Cooper V, Gellaitry G, Leake-Date H, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence

Overview

•  Overview of adherence in HIV care •  The nurses role in relation to adherence •  Existing research on adherence •  What interventions can be useful •  Experiences from practice

Page 4: Michelle Croston...Horne R, Cooper V, Gellaitry G, Leake-Date H, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence
Page 5: Michelle Croston...Horne R, Cooper V, Gellaitry G, Leake-Date H, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence

Is adherence a problem in your clinical practice?

Data from the UK suggests adherence to ART remains a substantial problem with those who accepted treatment, with over 30% having low adherence within 6 months of treatment initiation and with 13% failing to achieve virological suppression by 1 year follow up post treatment initiation. Horne R, Cooper V, Gellaitry G, Leake-Date H, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence. J Acquir Immune Defic Syndr. 2007; 45(3):334-41. Lima V, Harrigan R, Bangsberg D, Hogg R, Gross R, Yip B, et al. The Combined Effect of Modern Highly Active Antiretroviral Therapy Regimens and Adherence on Mortality Over Time. J Acquir Immune Defic Syndr. 2006;50(5):529-36. Deloria-Knoll M, Chmiel JS, Moorman AC, Wood KC, Holmberg SD, Palella FJ. Factors related to and consequences of adherence to antiretroviral therapy in an ambulatory HIV-infected patient cohort. AIDS Patient Care STDS. 2004 Dec;18(12):721-7. Weidle PJ, Ganera CE, Irwin KL, McGowan JP, Ernst JA, Olivo N, et al. Adherence to antiretroviral medications in an inner-city population. J Acquir Immune Defic Syndr. 1999 15;22(5):498-502. Harte D, Dosekun O, Sethi G, Chadborn T, de Ruiter A, Copas A, et al. Immunosuppression among HIV-1-positive patients attending for care: experience from two large HIV centres in the United Kingdom. HIV Med. 2010 Feb;11(2):114-20.

Page 6: Michelle Croston...Horne R, Cooper V, Gellaitry G, Leake-Date H, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence

Why is this a problem ? Patient v’s Public health

•  Low CD4 counts are associated with poorer outcomes on therapy

•  Once ART is commenced , continuous tx is necessary to ensure efficacy and prevent emergence of viral resistance and exhaustion of tx options

•  Public health perspective , a delay in achieving a detectable viral load increases the likelihood of onward transmission of a resistant virus

•  There are cost implication as a result of second line treatments

•  Increase demands on healthcare system due to opportunistic infections

Page 7: Michelle Croston...Horne R, Cooper V, Gellaitry G, Leake-Date H, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence

•  All patients should be given the opportunity to be involved in making decisions about their treatment

•  Treatment support should include, in-house, independent, community and peer support

•  Good trusting relationship and good communications skills increase adherence

Page 8: Michelle Croston...Horne R, Cooper V, Gellaitry G, Leake-Date H, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence

•  Focusing on assessing resistance for starting treatment – motivational interviewing style (WEMS)

•  Screen for adherence problems

•  Strategies based on Health Belief Model

•  Practical approaches to support, medication training (MEMS), DOT, pill boxes

•  Empowerment

Page 9: Michelle Croston...Horne R, Cooper V, Gellaitry G, Leake-Date H, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence

•  Look at predictors of non-adherence

•  No gold standard tool for assessing adherence, a variety of approaches may be helpful to identify the problem

•  Identify a variety of approaches to help - also provide a link to CDC’s good evidence medication adherence (research around adherence)

Page 10: Michelle Croston...Horne R, Cooper V, Gellaitry G, Leake-Date H, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence

NICE guidance of medicines adherence

Medicines  Adherence:  involving  patients  in  decisions  about  prescribed  medicines  and  supporting  adherence.  January  2009.  http://www.nice.org.uk/nicemedia/live/11766/42971/42971.pdf.  Accessed  July  2010.  

�  Assessing readiness

�  Patient involvement in decisions about medicine

�  Communication

�  Increasing patient involvement

�  Understanding the patient's knowledge, beliefs and concerns about medicines

�  Providing information

�  Supporting adherence

�  Assessing adherence

�  Interventions to increase adherence

�  Reviewing medicine

�  Communication between healthcare professionals

Page 11: Michelle Croston...Horne R, Cooper V, Gellaitry G, Leake-Date H, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence
Page 12: Michelle Croston...Horne R, Cooper V, Gellaitry G, Leake-Date H, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence

Determinants of adherence

What makes it easier to do?

Page 13: Michelle Croston...Horne R, Cooper V, Gellaitry G, Leake-Date H, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence

Horne,  R.  Concordance,  Adherence  and  Compliance  in  Medicine-­‐Taking.  Report  for  the  National  Co-­‐ordinating  Centre  for  NHS  Service  and  Delivery  Organisation  R&D  (NCCSDO)  (2005),  pp  139.    

Map of determinants of adherence

Page 14: Michelle Croston...Horne R, Cooper V, Gellaitry G, Leake-Date H, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence

What theories can help explain non- adherence?

•  Various social cognition models such as Health Belief Model (HBM) , the Theory of Reasoned Action and (TRA) and the revised Theory of Planned Behavior (TPB) have been used to explain a variety of non adherence behavior.

For example , beliefs that failure to take treatment could result in adverse consequences and the person is personally susceptible to these effects tends to be associated with higher levels of adherence.

Page 15: Michelle Croston...Horne R, Cooper V, Gellaitry G, Leake-Date H, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence

•  Leventhal’s  self  regulatory  model  of  illness  (SRM)  

Adherence  will  be  more  likely  if  the  paBent  perceives  the  advice  to  take  treatment  makes  ‘common-­‐sense’  in  the  light  of  their  experiences  and  their  personal  beliefs  about  adherence.    

Page 16: Michelle Croston...Horne R, Cooper V, Gellaitry G, Leake-Date H, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence

Perspectives on adherence and simplicity

Stone V et al. J Acquir Immune Defic Syndr 2004;36:808–16

•  The top three most helpful predictors of adherence: –  Pill count –  Dosing frequency

(qd, with pills taken at the same time each day)

–  Adverse events

Page 17: Michelle Croston...Horne R, Cooper V, Gellaitry G, Leake-Date H, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence

Existing research

 •   In  2006  two  meta  analysis  found  some  intervenBons  improved  ART  adherence  but  effecBve  sizes  were  typically  low  (odds  raBo  (OR)=  1.50  95%  confidence  interval  (CI)1.16  to  1.94)    •   Cogni&ve  behavior  therapy  (CBT)  Safren  et  al  2009  highlighted  the  effecBveness  of  CBT  to  non-­‐adherence  and  depression  for  PLHV  in  their  RCT.  Amico  KR,  Harman  JJ,  Johnson  BT.  Efficacy  of  anBretroviral  therapy  adherence  intervenBons:  a  research  synthesis  of  trials,  1996  to  2004.  J  Acquir  Immune  Defic  Syndr.  2006  Mar;41(3):285-­‐9      Simoni  JM,  Pearson  CR,  Pantalone  DW,  Marks  G,  Crepaz  N.  Efficacy  of  intervenBons  in  improving  highly  acBve  anBretroviral  therapy  adherence  and  HIV-­‐1  RNA  viral  load.  A  meta-­‐analyBc  review  of  randomized  controlled  trials.  J  Acquir  Immune  Defic  Syndr.  2006  Dec  1;43  Suppl  1:S23-­‐35.    Safren  SA,  O’Cleirigh  C  et  al  A  randomized  control  trial  of  CogniBve  behaviour  therapy  for  adherence  and  depression  (CBT-­‐AD)  in  HIV  infected  individuals.  Health  Psychol  2009,  Jan  ,  28  ,  (1):  1-­‐10    

 

Page 18: Michelle Croston...Horne R, Cooper V, Gellaitry G, Leake-Date H, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence

•  Mo&va&onal  Interviewing  (MI)is  well  cited  as  being  effecBve  when  providing  adherence  support  (  Hill  et  al  2012).  Golin  et  al  2006  RCT  explores  the  use  of  MI    in  relaBon  to  adherence  support.  

•  Counseling  and  alarm  advice  Griffiths  et  al  2007  highlights  the  role  of  counselling  and  adherence  support  delivered  by  nurses/pharmacist  showing  a  posiBve  correlaBon  as  did  Lester  et  al    2010  RCT  and  Chung  et  al  2011  exploratory  research.  

Hill,  Seth  and  Kavookkjian  (2012)MoBvaBonal  interviewing  as  a  behavioral  intervenBon  to  increase  ART  adherence  in  paBents  who  are  HIV  posiBve  .  A  systemaBc  review  of  the  literature.  AIDS  care  ,  24  (5)  583-­‐592    

Golin  CE  ,  Earp  J  et  al  2  arm  ,  randomised  ,  controlled  trial  of  a  moBvaBonal  interviewing  based  intervenBon  to  improve  adherence  to  anBretroviral  therapy  (ART)  among  paBents  failing  or  iniBaBng  ART.  J  Acquir  Immune  Defic  Syndr  2006  May  ,  1,  42-­‐51    

Griffiths  ,  C  et  al  2007  A  nurse  and  pharmacist  –led  treatment  advice  clinic  for  paBents  alending  an  HIV  outpaBents  clinic  ,  Journal  of  advance  nursing  ,  58,  4,  320-­‐326    Lester,  Richard  T  et  al  (  2010)  Effects  of  a  mobile  phone  short  message  service  on  anBviral  treatment  adherence  in  Kenya  A  randomised  control  trial.  Lancet,  376  (  9755)  1838-­‐1845  Chung  ,  MH,  Richardson  ,  BA  et  al  (2011)  A  randomised  controlled  trial  comparing  the  effects  of  counselling  and  alarm  device  on  HAART  adherence  and  virologic  outcome.  Plos  medicine  ,  3,  

e1000422  

Page 19: Michelle Croston...Horne R, Cooper V, Gellaitry G, Leake-Date H, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence

How well do we sell adherence as nurses ?

Pre treatment • Preparing patients for ARV’s • Assessing acceptance of HIV • Checking patients mood • Passing on knowledge of HIV and treatment • Preparing to manage side effects • Assessing motivation/ Self efficacy

• Exploring Strategies to help patients remember treatment

de Bruin M, Hospers HJ, van den Borne HW, Kok G, Prins JM. Theory- and evidence-based intervention to improve adherence to antiretroviral therapy among HIV-infected patients in the Netherlands: a pilot study. AIDS Patient Care STDS. 2005 Jun;19(6):384-94

Page 20: Michelle Croston...Horne R, Cooper V, Gellaitry G, Leake-Date H, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence

Strategies during the treatment phase •  Discussing non-

adherence •  Discussion solutions to

the demands of ARV •  Discussing motivation

to change •  Evaluating and

assessing side effects

•  Evaluating

ambivalence •  Explaining lab results

•  Changing treatment

•  Discussing forgotten treatment

•  Passing on knowledge

•  Evaluating support

Bruin M, Hospers HJ, van den Borne HW, Kok G, Prins JM. Theory- and evidence-based intervention to improve adherence to antiretroviral therapy among HIV-infected patients in the Netherlands: a pilot study. AIDS Patient Care STDS. 2005 Jun;19(6):384-94

Page 21: Michelle Croston...Horne R, Cooper V, Gellaitry G, Leake-Date H, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence

Strategies used in all phases of the patients journey •  Offering support •  Assessing for

psychological distress •  Building relationships •  Providing ongoing

education/support •  Onwards referral to

services

Bruin M, Hospers HJ, van den Borne HW, Kok G, Prins JM. Theory- and evidence-based intervention to improve adherence to antiretroviral therapy among HIV-infected patients in the Netherlands: a pilot study. AIDS Patient Care STDS. 2005 Jun;19(6):384-94

Page 22: Michelle Croston...Horne R, Cooper V, Gellaitry G, Leake-Date H, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence

Adherence support

Page 23: Michelle Croston...Horne R, Cooper V, Gellaitry G, Leake-Date H, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence

Creating a trusting relationship

•  Holistic assessment •  Cue based

communication •  Motivational Interview •  Goal setting and

negotiation •  Promotion of self

efficacy and self care •  Development of

decision making skills

�  Assessing readiness to start treatment

�  Education and empowerment

�  Use of affirmation

�  Side effect management

�  Referrals – MDT approach essential

�  Unconditional support

�  Peer support

Page 24: Michelle Croston...Horne R, Cooper V, Gellaitry G, Leake-Date H, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence

Medication boxes

Page 25: Michelle Croston...Horne R, Cooper V, Gellaitry G, Leake-Date H, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence

Alternative beliefs

Page 26: Michelle Croston...Horne R, Cooper V, Gellaitry G, Leake-Date H, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence
Page 27: Michelle Croston...Horne R, Cooper V, Gellaitry G, Leake-Date H, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence
Page 28: Michelle Croston...Horne R, Cooper V, Gellaitry G, Leake-Date H, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence
Page 29: Michelle Croston...Horne R, Cooper V, Gellaitry G, Leake-Date H, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence

Submit an article

•  Original research

•  Nursing innovations

•  Audit

Page 30: Michelle Croston...Horne R, Cooper V, Gellaitry G, Leake-Date H, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence
Page 31: Michelle Croston...Horne R, Cooper V, Gellaitry G, Leake-Date H, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence
Page 32: Michelle Croston...Horne R, Cooper V, Gellaitry G, Leake-Date H, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence